drugset / Trial / NCT01155336
The Effects of Lovaza® in Acute Myocardial Infarction
Phase 1/2
Terminated
4 enrolled
University of Rochester
Albany College of Pharmacy and Health Sciences · collabGlaxoSmithKline · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will explore the safety and effectiveness of adding Lovaza® to the therapeutic program utilized internationally for the treatment of individuals with acute coronary syndromes.
Timeline
- Start
- 2010-06
- Primary completion
- 2011-05
- Completion
- 2011-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lovaza | Other / unclassified | 4 g | — |